Literature DB >> 30646812

miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1.

Jian Zhou1, Ying Zhang2, Zhaofeng Han1, Zhiwei Dong3, Tongtong Cao4, Aizhou Wei1, Pengfei Guo1, Qingnan Meng1.   

Abstract

Previous research has shown that microRNA 506 (miR-506) functions as an essential modulator in the development of many biological reactions, including multiple cancers. However, its involvement in cutaneous squamous cell carcinoma (CSCC) has been rarely reported. In the present work, we investigated the molecular mechanism and function of miR-506 in the regulation of CSCC cell viability and metastasis (migration and invasion). We observed that miR-506 expression was upregulated in both CSCC tissues and cell lines, and that decreased miR-506 expression led to repressed tumorigenesis in CSCC cells. Furthermore, flow cytometry revealed that the depletion of miR-506 resulted in decreased proliferation and increased apoptotic levels in CSCC cells. Meanwhile, it was found that miR-506 decreased CSCC cell migration and invasion in vitro. The dual-luciferase reporter assay also revealed that miR-506 targets the 3'-UTRs of p65 and Laminin C1 (LAMC1) for silencing. Silencing of p65 expression counteracted the pro-apoptotic influence of miR-506 depletion in CSCC cells, while inhibition of LAMC1 expression restored the migration and invasion properties of the CSCC cells. Therefore, the results provide evidence for the need to probe the biological and molecular mechanisms behind the development and progression of CSCC and may lead to novel treatment CSCC strategies.

Entities:  

Keywords:  LAMC1; MiR-506; apoptosis; cutaneous squamous cell carcinoma; metastasis; p65

Year:  2019        PMID: 30646812      PMCID: PMC6380411          DOI: 10.1080/15384101.2019.1568747

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  35 in total

Review 1.  Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.

Authors:  S Gerondakis; R Grumont; R Gugasyan; L Wong; I Isomura; W Ho; A Banerjee
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

Review 2.  NF-κB pathways in hematological malignancies.

Authors:  Chiara Gasparini; Claudio Celeghini; Lorenzo Monasta; Giorgio Zauli
Journal:  Cell Mol Life Sci       Date:  2014-01-14       Impact factor: 9.261

3.  Overexpression of her-2 associated with the progression of esophageal cancer patients.

Authors:  Gongchao Wang; Wenwen Zhang; Wenjing Jiang; Linlin Luan
Journal:  Hepatogastroenterology       Date:  2013 Nov-Dec

4.  Silencing of microRNA families by seed-targeting tiny LNAs.

Authors:  Susanna Obad; Camila O dos Santos; Andreas Petri; Markus Heidenblad; Oliver Broom; Cristian Ruse; Cexiong Fu; Morten Lindow; Jan Stenvang; Ellen Marie Straarup; Henrik Frydenlund Hansen; Troels Koch; Darryl Pappin; Gregory J Hannon; Sakari Kauppinen
Journal:  Nat Genet       Date:  2011-03-20       Impact factor: 38.330

5.  Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.

Authors:  D C Duffey; Z Chen; G Dong; F G Ondrey; J S Wolf; K Brown; U Siebenlist; C Van Waes
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

6.  Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.

Authors:  M van Hogerlinden; B L Rozell; L Ahrlund-Richter; R Toftgård
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

7.  NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

Authors:  Maya Dajee; Mirella Lazarov; Jennifer Y Zhang; Ti Cai; Cheryl L Green; Alan J Russell; M Peter Marinkovich; Shiying Tao; Qun Lin; Yoshiaki Kubo; Paul A Khavari
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

8.  Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.

Authors:  Jin Zheng; Chuize Kong; Xiaoxi Yang; Xiaolu Cui; Xuyong Lin; Zhe Zhang
Journal:  BMC Cancer       Date:  2017-06-19       Impact factor: 4.430

9.  Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma.

Authors:  Qifeng Wang; Hongxia Zhu; Zefen Xiao; Wencheng Zhang; Xiao Liu; Xun Zhang; Jie He; Kelin Sun; Lvhua Wang; Ningzhi Xu
Journal:  World J Surg Oncol       Date:  2013-10-16       Impact factor: 2.754

Review 10.  The emerging role of miR-506 in cancer.

Authors:  Jian Li; Jingfang Ju; Bing Ni; Huaizhi Wang
Journal:  Oncotarget       Date:  2016-09-20
View more
  5 in total

1.  CircRNA circ_0067772 aggravates the malignant progression of cutaneous squamous cell carcinoma by regulating miR-1238-3p/FOXG1 axis.

Authors:  Xiaoqing Li; Yinghui Kong; He Li; Manyuan Xu; Ming Jiang; Weiguo Sun; Suping Xu
Journal:  Genes Genomics       Date:  2021-03-11       Impact factor: 1.839

2.  Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.

Authors:  Bowen Diao; Ping Yang
Journal:  Pathol Oncol Res       Date:  2021-08-25       Impact factor: 3.201

Review 3.  Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.

Authors:  Stephenie Droll; Xiaomin Bao
Journal:  Cell Physiol Biochem       Date:  2021-09-22

4.  MicroRNA-573 inhibits cell proliferation, migration and invasion and is downregulated by PICSAR in cutaneous squamous cell carcinoma.

Authors:  Yanhua Wang; Shengjian Tang; Jianping Lv
Journal:  Bosn J Basic Med Sci       Date:  2022-04-01       Impact factor: 3.759

Review 5.  Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms.

Authors:  Fei Liu; Shenglong Li
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.